242 related articles for article (PubMed ID: 29611883)
1. Synthesis, p38α MAP kinase inhibition, anti-inflammatory activity, and molecular docking studies of 1,2,4-triazole-based benzothiazole-2-amines.
Tariq S; Alam O; Amir M
Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700304. PubMed ID: 29611883
[TBL] [Abstract][Full Text] [Related]
2. 1,2,4-Triazole-based benzothiazole/benzoxazole derivatives: Design, synthesis, p38α MAP kinase inhibition, anti-inflammatory activity and molecular docking studies.
Tariq S; Kamboj P; Alam O; Amir M
Bioorg Chem; 2018 Dec; 81():630-641. PubMed ID: 30253336
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, evaluation and docking of novel pyrazolo pyrimidines as potent p38α MAP kinase inhibitors with improved anti-inflammatory, ulcerogenic and TNF-α inhibitory properties.
Somakala K; Tariq S; Amir M
Bioorg Chem; 2019 Jun; 87():550-559. PubMed ID: 30928877
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, anti-inflammatory, p38α MAP kinase inhibitory activities and molecular docking studies of quinoxaline derivatives containing triazole moiety.
Tariq S; Alam O; Amir M
Bioorg Chem; 2018 Feb; 76():343-358. PubMed ID: 29227918
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and anti-inflammatory activity of imidazol-5-yl pyridine derivatives as p38α/MAPK14 inhibitor.
Ali EMH; Abdel-Maksoud MS; Hassan RM; Mersal KI; Ammar UM; Se-In C; He-Soo H; Kim HK; Lee A; Lee KT; Oh CH
Bioorg Med Chem; 2021 Feb; 31():115969. PubMed ID: 33422910
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, biological evaluation, and in silico studies of quinoxaline derivatives as potent p38α MAPK inhibitors.
Anjali ; Kamboj P; Alam O; Patel H; Ahmad I; Ahmad SS; Amir M
Arch Pharm (Weinheim); 2024 Jan; 357(1):e2300301. PubMed ID: 37847883
[TBL] [Abstract][Full Text] [Related]
7. Substituted Benzamides from Anti-inflammatory and p38 Kinase Inhibitors to Antitubercular Activity: Design, Synthesis and Screening.
Kulkarni R; Mitkari U; Achaiah G; Laufer S; Bikshapti DVRN; Chandrashekar VM; Gurav PB; Joshi SJ; Chipade VD
Mini Rev Med Chem; 2018; 18(17):1486-1497. PubMed ID: 28685700
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological testing of N-aminoimidazole-based p38alpha MAP kinase inhibitors.
Bracht C; Hauser DR; Schattel V; Albrecht W; Laufer SA
ChemMedChem; 2010 Jul; 5(7):1134-42. PubMed ID: 20473979
[TBL] [Abstract][Full Text] [Related]
9. Syntheses and structure-activity relationships for some triazolyl p38α MAPK inhibitors.
Seerden JP; Leusink-Ionescu G; Leguijt R; Saccavini C; Gelens E; Dros B; Woudenberg-Vrenken T; Molema G; Kamps JA; Kellogg RM
Bioorg Med Chem Lett; 2014 Mar; 24(5):1352-7. PubMed ID: 24508134
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, anti-inflammatory activity, and molecular docking studies of perimidine derivatives containing triazole.
Zhang HJ; Wang XZ; Cao Q; Gong GH; Quan ZS
Bioorg Med Chem Lett; 2017 Sep; 27(18):4409-4414. PubMed ID: 28823493
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of novel 1
Liu J; Wen Y; Gao L; Gao L; He F; Zhou J; Wang J; Dai R; Chen X; Kang D; Hu L
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):72-84. PubMed ID: 31682465
[TBL] [Abstract][Full Text] [Related]
12. CGH2466, a combined adenosine receptor antagonist, p38 mitogen-activated protein kinase and phosphodiesterase type 4 inhibitor with potent in vitro and in vivo anti-inflammatory activities.
Trifilieff A; Keller TH; Press NJ; Howe T; Gedeck P; Beer D; Walker C
Br J Pharmacol; 2005 Apr; 144(7):1002-10. PubMed ID: 15685201
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of 4-fluorophenyl-imidazole p38α MAPK, CK1δ and JAK2 kinase inhibitors.
Seerden JP; Leusink-Ionescu G; Woudenberg-Vrenken T; Dros B; Molema G; Kamps JA; Kellogg RM
Bioorg Med Chem Lett; 2014 Aug; 24(15):3412-8. PubMed ID: 24930833
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of N-cyclopropylbenzamide-benzophenone hybrids as novel and selective p38 mitogen activated protein kinase (MAPK) inhibitors.
Heo J; Shin H; Lee J; Kim T; Inn KS; Kim NJ
Bioorg Med Chem Lett; 2015 Sep; 25(17):3694-8. PubMed ID: 26115577
[TBL] [Abstract][Full Text] [Related]
15. The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors.
Sabatini S; Manfroni G; Barreca ML; Bauer SM; Gargaro M; Cannalire R; Astolfi A; Brea J; Vacca C; Pirro M; Massari S; Tabarrini O; Loza MI; Fallarino F; Laufer SA; Cecchetti V
Chem Biol Drug Des; 2015 Oct; 86(4):531-45. PubMed ID: 25589097
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, pharmacological screening and in silico studies of new class of Diclofenac analogues as a promising anti-inflammatory agents.
Palkar MB; Singhai AS; Ronad PM; Vishwanathswamy AH; Boreddy TS; Veerapur VP; Shaikh MS; Rane RA; Karpoormath R
Bioorg Med Chem; 2014 May; 22(10):2855-66. PubMed ID: 24751552
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 5-(fluoro-substituted-6-methylpyridin-2-yl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazoles as inhibitors of transforming growth factor-β type I receptor kinase.
Krishnaiah M; Jin CH; Sheen YY; Kim DK
Bioorg Med Chem Lett; 2015 Nov; 25(22):5228-31. PubMed ID: 26483198
[TBL] [Abstract][Full Text] [Related]
18. Benzothiazole based inhibitors of p38alpha MAP kinase.
Liu C; Lin J; Pitt S; Zhang RF; Sack JS; Kiefer SE; Kish K; Doweyko AM; Zhang H; Marathe PH; Trzaskos J; Mckinnon M; Dodd JH; Barrish JC; Schieven GL; Leftheris K
Bioorg Med Chem Lett; 2008 Mar; 18(6):1874-9. PubMed ID: 18296051
[TBL] [Abstract][Full Text] [Related]
19. Zebrafish, a model to develop nanotherapeutics that control neutrophils response during inflammation.
García-López JP; Vilos C; Feijóo CG
J Control Release; 2019 Nov; 313():14-23. PubMed ID: 31622693
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of trisubstituted imidazole derivatives as inhibitors of p38alpha mitogen-activated protein kinase.
Kim DK; Lim JH; Lee JA; Dewang PM
Bioorg Med Chem Lett; 2008 Jul; 18(14):4006-10. PubMed ID: 18571921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]